To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: Copaxone Slows Progression Of Disability, Reduces Relapses In MS URL: http://www.pslgroup.com/dg/634EA.htm Doctor's Guide March 23, 1998
TORONTO, ON -- March 18, 1998 – Research published in the current issue of Neurology shows that Copaxone(R) (glatiramer acetate for injection) can actually slow the progression of relapse-remitting Multiple Sclerosis (MS). The researchers found that Copaxone reduces the number of relapses and slows the progression of disability in patients with relapsing-remitting multiple sclerosis. A clinical trial that ran for nearly three years has shown that the longer patients take Copaxone(R), the better the results compared to placebo. The research, conducted at 11 medical centres in the United States, has significant implications for Canadians with multiple sclerosis. Multiple sclerosis is a chronic, often progressive disease of the central nervous system (brain, spinal cord and optic nerves), which affects 300,000 people in the United States (Approximately 10,000 people are diagnosed each year). The disease most often appears in people between the ages of 20 and 40 -- approximately 73 percent of people with multiple sclerosis are female. More information on: Copaxone. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.